K982231

Substantially Equivalent

STATUSFLOW

Applicant: R&D Systems, Inc.
Product code: GKZ
Advisory panel: Hematology
Date received: 1998-06-25
Decision date: 1998-07-20
Decision: Substantially Equivalent
Clearance type: Special
Location: Minneapolis, MN, US

Adverse events under product code GKZ

product code GKZ

Malfunction: 1,205
Total: 1,205

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.